New proprietary RF hardware delivers
significantly enhanced signal fidelity
PLEASANTON, Calif., Feb. 4, 2025
/PRNewswire/ -- Movano Health (Nasdaq: MOVE) announced today that
it has commenced a blood pressure clinical trial with its newly
developed cuffless blood pressure wrist wearable. The study, which
is expected to include at least 70 participants and be completed
during the second week of February, utilizes the updated device to
monitor pulse pressure waveforms in comparison with a hospital
grade blood pressure device. The new wearable will also collect
data on a host of other vital signs including pulse rate, blood
oxygen saturation (SpO2), respiration rate and ECG
waveforms.
"We have learned a great deal since our last clinical trial in
November 2024 and have refined the
use of our proprietary cuffless blood pressure wearable in order to
extract higher fidelity data," said Movano Health's CTO
and Founder Michael Leabman. "I'm excited about the potential
the enhanced design offers relative to our previous prototype as it
represents a significant leap forward in cuffless blood pressure
monitoring."
The February 2025 study follows
three clinical trials that took place in November 2024,
June 2024 and October 2023 where the Company used its
non-invasive devices to collect pulse pressure waveform data from
over 60 participants of varying gender, age, ethnicity and BMI.
During each session, participants wore Movano
Health's wrist-worn device along with a hospital-grade
FDA-cleared vital signs monitor with cuffed blood pressure
measurements or utilizing arterial blood pressure data as the
control. In mid-2025, the Company plans on executing an
additional 100-150 person continuous-blood pressure study using an
arterial line, the results of which would help finalize the
algorithm expected to be used in a future FDA pivotal trial.
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE)
dba Movano Health, maker of the Evie Ring (www.eviering.com),
is developing a suite of purpose-driven healthcare solutions to
bring medical-grade data to the forefront of wearables. Featuring
modern and flexible form factors, Movano Health's devices
offer an innovative approach to delivering trusted data to both
customers and enterprises, capturing a comprehensive picture of an
individual's health data and uniquely translating it into
personalized and intelligent insights.
Movano Health is developing its proprietary technologies
and wearable medical device solutions to enable the future use of
data as a tool to proactively monitor and manage health outcomes
across a number of patient populations that exist in healthcare.
For more information on Movano Health,
visit https://movanohealth.com/.
Forward Looking Statements
This press release contains forward-looking statements
concerning our expectations, anticipations, intentions, beliefs, or
strategies regarding the future. These forward-looking statements
are based on assumptions that we have made as of the date hereof
and are subject to known and unknown risks and uncertainties that
could cause actual results, conditions, and events to differ
materially from those anticipated. Therefore, you should not place
undue reliance on forward-looking statements. Examples of
forward-looking statements include, among others, statements we
make regarding plans with respect to the commercial launches of the
Evie Ring and EvieMED Ring; our expectations regarding potential
commercial opportunities; planned cost-cutting initiatives;
anticipated FDA clearance decisions with respect to our products;
expected future operating results; product development and
features, product releases, clinical trials and regulatory
initiatives; our strategies, positioning and expectations for
future events or performance. Important factors that could cause
actual results to differ materially from those in the
forward-looking statements are set forth in our most recent Annual
Report on Form 10-K and any subsequent Quarterly Reports on Form
10-Q, and in our other reports filed with the Securities and
Exchange Commission, including under the caption "Risk
Factors." Any forward-looking statement in this release
speaks only as of the date of this release. We undertake no
obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-health-commences-clinical-study-with-new-cuffless-blood-pressure-device-302366923.html
SOURCE Movano
